We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.35%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.33%
2 Technology 14.8%
3 Healthcare 13.84%
4 Industrials 13.25%
5 Energy 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IEX icon
126
IDEX
IEX
$17B
$10.8M 0.24%
133,800
+2,200
+2% +$166K
V icon
127
Visa
V
$701B
$10.7M 0.24%
202,568
– –
MYGN icon
128
Myriad Genetics
MYGN
$476M
$10.6M 0.24%
272,700
-197,100
-42% -$7.33M
APH icon
129
Amphenol
APH
$185B
$10.4M 0.23%
865,600
– –
TRN icon
130
Trinity Industries
TRN
$2.92B
$10.1M 0.23%
+321,737
New +$9.12M
LXK
131
DELISTED
Lexmark Intl Inc
LXK
$10.1M 0.22%
209,363
+155,700
+290% +$6.95M
BALL icon
132
Ball Corp
BALL
$17.5B
$10.1M 0.22%
321,090
– –
HUB.B
133
DELISTED
HUBBELL INC CL-B
HUB.B
$9.84M 0.22%
79,877
-21,300
-21% -$2.52M
CVC
134
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$9.57M 0.21%
+542,300
New +$9.27M
PRE
135
DELISTED
PARTNERRE LTD
PRE
$9.51M 0.21%
87,100
+11,300
+15% +$1.19M
PM icon
136
Philip Morris
PM
$309B
$9.46M 0.21%
112,200
-1,986
-2% -$171K
TRW
137
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$9.44M 0.21%
105,500
+42,100
+66% +$3.52M
MS icon
138
Morgan Stanley
MS
$319B
$9.42M 0.21%
291,335
-6,500
-2% -$200K
PPC icon
139
Pilgrim's Pride
PPC
$7.13B
$9.39M 0.21%
343,300
+140,800
+70% +$3.34M
WDC icon
140
Western Digital
WDC
$159B
$9.33M 0.21%
133,790
-7,153
-5% -$479K
MUR icon
141
Murphy Oil
MUR
$5.55B
$9.15M 0.2%
137,700
– –
VRSN icon
142
VeriSign
VRSN
$26.3B
$9.06M 0.2%
185,700
-500
-0.3% -$24.9K
UHS icon
143
Universal Health Services
UHS
$10.2B
$9.05M 0.2%
94,555
– –
LII icon
144
Lennox International
LII
$15B
$8.99M 0.2%
100,400
-166,300
-62% -$14.5M
XLNX
145
DELISTED
Xilinx Inc
XLNX
$8.98M 0.2%
189,900
-119,700
-39% -$5.76M
AME icon
146
Ametek
AME
$53.9B
$8.96M 0.2%
171,350
– –
DTE icon
147
DTE Energy
DTE
$29.9B
$8.95M 0.2%
135,067
-33,958
-20% -$2.2M
NVR icon
148
NVR
NVR
$17.1B
$8.86M 0.2%
7,700
– –
INTC icon
149
Intel
INTC
$413B
$8.85M 0.2%
286,400
+42,900
+18% +$1.18M
AVGO icon
150
Broadcom
AVGO
$1.76T
$8.84M 0.2%
1,227,000
– –
4 5
6
7 8

Similar funds

BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM
FFIM
Founders Fund IV Management San Francisco, California $1.21M AUM

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.